RM (RM) holder reports planned Rule 144 sale of common stock

Rhea-AI Filing Summary

A shareholder of RM filed a Rule 144 notice covering planned sales of a small amount of the company’s common stock. The notice lists 14 shares of common stock, par value $0.10, to be sold through J.P. Morgan Securities LLC, with an aggregate market value of 525, when there are 9,712,805 shares outstanding. The proposed sale date is 11/26/2025 on the NYSE.

The securities to be sold were originally acquired as common stock on 03/24/2014 via open market purchases and/or transfers from affiliates, with 6,278 shares acquired for cash on that date. Over the prior three months, the same fund sold additional blocks of RM common stock: 234 shares on 11/25/2025 for proceeds of 8,629.92, 203 shares on 11/24/2025 for 7,411, and 374 shares on 11/21/2025 for 13,665.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock, par value $0.10 (???Common Stock???)	J.P. Morgan Securities LLC 270 Park Avenue New York NY 10017	14	525	9712805	11/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/24/2014	(3)	Open Market and/or Transfers from Affiliates			6278	03/24/2014	Cash (3)

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Basswood Financial Fund, Ltd 979 Batesville Road Suite B Greer SC 29651	Common Stock	11/25/2025	234	8629.92
Basswood Financial Fund, Ltd. 979 Batesville Road Suite B Greer SC 29651	Common Stock	11/24/2025	203	7411
Basswood Financial Fund, Ltd 979 Batesville Road Suite B Greer SC 29651	Common Stock	11/21/2025	374	13665

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for RM common stock disclose?

The filing discloses that a shareholder has given notice under Rule 144 of an intended sale of 14 shares of RM common stock, par value $0.10, through J.P. Morgan Securities LLC on or about 11/26/2025 on the NYSE.

How many RM shares are planned to be sold under this Rule 144 notice?

The notice covers the proposed sale of 14 shares of RM common stock with an aggregate market value of 525.

How many RM shares are outstanding compared to the amount in this sale?

The table states there are 9,712,805 shares outstanding of RM common stock. The planned Rule 144 sale involves 14 shares, which is a very small portion of this outstanding amount.

When and how were the RM shares being sold originally acquired?

The securities to be sold are common stock acquired on 03/24/2014 through open market and/or transfers from affiliates. On that date, 6,278 shares were acquired for cash.

What RM stock sales has the shareholder made in the past three months?

The filing lists prior sales by the fund of RM common stock: 234 shares on 11/25/2025 for 8,629.92, 203 shares on 11/24/2025 for 7,411, and 374 shares on 11/21/2025 for 13,665.

Who is the selling holder in this RM Form 144 filing?

The table of recent sales identifies the seller as Basswood Financial Fund, Ltd, with an address at 979 Batesville Road, Suite B, Greer, SC 29651.

What representation does the seller make about RM’s information in this notice?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.